Structural changes in the renal vasculature in streptozotocin-induced diabetic rats without hypertension

Nephron - Physiology

Volumn 99, Issue 2, 2005, Pages

  Joo Turoni, Claudio M ^a   Reynoso, Héctor A ^a   Marañón, Rodrigo O ^a   Coviello, Alfredo ^a   Peral De Bruno, María ^a  

^a UNIVERSIDAD NACIONAL DE TUCUMÁN   (Argentina)

Author keywords

Diabetic glomerulopathy; Kidney; Renalvascular wall thickening; Streptozotocin

Indexed keywords

STREPTOZOCIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTERIOLE; ARTERIOSCLEROSIS; ARTICLE; BASEMENT MEMBRANE; CAPILLARY WALL; CONTROLLED STUDY; DENSITY; GLOMERULUS; HEALTH STATUS; HISTOPATHOLOGY; HYPERTENSION; KIDNEY BLOOD VESSEL; KIDNEY DISTAL TUBULE; KIDNEY INJURY; KIDNEY PARENCHYMA; KIDNEY PROXIMAL TUBULE; KIDNEY TUBULE DAMAGE; MALE; MESANGIUM; NONHUMAN; PRIORITY JOURNAL; RAT; SCORING SYSTEM; STEREOLOGY; STREPTOZOCIN DIABETES; VASCULARIZATION;

ANIMALS; ATHEROSCLEROSIS; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; HYPERTENSION; KIDNEY; MALE; MICROCIRCULATION; RATS; RATS, SPRAGUE-DAWLEY; STREPTOZOCIN;

EID: 13244270148     PISSN: 16602137     EISSN: None     Source Type: Journal    
DOI: 10.1159/000083136     Document Type: Article

References (28)

1. Geerlings W, Tufveson G, Ehrich JH, Jones EH, Landais P, Loirat C, Mallick NP, Margreiter R, Raine AE, Salmela K: Report on management of renal failure in Europe, XXIII. Nephrol Dial Transplant 1994;9(suppl 1):6-25.
2. Krowlesky A, Warran J, Rand L, Kahn C: Epidemiologic approach to the etiology of type I diabetes mellitus and its complications. N Engl J Med 1987;317:1390-1398.
3. Jacobsen P, Rossing K, Tarnow L, Rossing P, Mallet C, Poirier O, Cambien F, Parving HH: Progression of diabetic nephropathy in normotensive type 1 diabetic patients. Kidney Int 1999;71:S101-S105.
4. Hocher B, Schwarz A, Reinbancher D, Jacobi J, Lun A, Priem F, Bauer C, Neumayer H, Raschack M: Effects of endothelin receptor antagonists on the progression of diabetic nephropathy. Nephron 2000;87:161-169.
5. Isogai S, Mogami K, Shiina N, Yoshino G: Initial ultrastructural changes in pore size and anionic sites of the glomerular basement membrane in streptozotocin-induced diabetic rats and their prevention by insulin treatment. Nephron 1999;83:53-58.
6. Østerby R, Gall M, Schmitz A, Nielsen F, Nyberg G, Parving H: Glomerular structure and function in proteinuric type 2 (non-insulin-dependent) diabetic patients. Diabetologia 1993;36:1064-1070.
7. Hilgers K, Mann J: Role of angiotensin II in glomerular injury: Lessons from experimental and clinical studies. Kidney Blood Press Res 1996;19:254-262.
8. Schleicher F, Kolm V, Ceol M, Nerlich A: Structural and functional changes in diabetic glomerulopathy. Kidney Blood Press Res 1996;19:305-315.
9. Peral M, Joo Turoni C, Marañón R, Reynoso H, Coviello A: Structural changes in the kidney induced by coarctation hypertension. Clin Exp Hypertens 2001;23:501-511.
10. Gajdosik A, Gajdosikova A, Stefek M, Navarova J, Hozova R: Streptozotocin-induced experimental diabetes in male Wistar rats. Gen Physiol Biophys 1999;18:54-62.
11. Weibel ER, Kistler GS, Scherle WF: Practical stereological methods for morphometric cytology. J Cell Biol 1966;30:23-28.
12. Cooper M, Allen T, O'Brien R, Macmillan P, Clarcke B, Jerums G, Doyle A: Effects of genetic hypertension on diabetic nephropathy in the rat - Functional and structural characteristics. J Hypertens 1988;6:1009.
13. Christensen PK, Larsen S, Horn T, Olsen S, Parving HH: Renal function and structure in albuminuric type 2 diabetic patients without retinopathy. Nephrol Dial Transplant 2001;16:2337-2347
14. Wenzel U, Thaiss F, Panzer U, Schneider A, Schwietzer G, Helmchen U, Stahl RA: Effect of renovascular hypertension on experimental glomerulonephritis in rats. J Lab Clin Med 1999;134:292-303.
15. Parving H, Andersen A, Smidt U, Svendsen P: Early aggressive antihypertensive treatment reduces rate of decline in kidney function in diabetic nephropathy. Lancet 1983;i:1175-1179.
16. Lewis E, Hunsicker L, Bain R, Rohde R: The effect of angiotensin- converting enzyme inhibition on diabetic nephropathy. N Engl J Med 1993;47:1456-1462.
17. Tojo A, Onozato ML, Ha H, Kurihara H, Sakai T, Goto A, Fujita T, Endou H: Reduced albumin reabsorption in the proximal tubule of early-stage diabetic rats. Histochem Cell Biol 2001;116:269-276.
18. Seyer-Hansen K: Renal hypertrophy in experimental diabetes mellitus. Kidney Int 1983;23:643-646.
19. Christoph J, Geissinger B: Renal hypertrophy in streptozotocin diabetic rats: Role of proteolytic lysosomal enzymes. Kidney Int 1992;41:966-972.
20. Montgensen C, Andersen M: Increased kidney size and glomerular filtration rate in untreated juvenile diabetes: Normalization by insulin treatment. Diabetologia 1975;11:221-224.
21. Wesson LG: Compensatory growth and other growth responses of the kidney. Nephron 1989;51:149-184.
22. Farina N, Hodgson W, Widdop R: Vascular reactivity to angiotensin II in the blood perfused kidneys of hypertensive diabetic rats. Eur J Pharmacol 1996;310:185-191.
23. Sarubbi D, McGiff J, Quilley J: Renal vascular responses and eicosanoid release in diabetic rats. Am J Physiol 1989;257:F762-F768.
24. Anderson W, Kett M, Evans RG, Alcorn D: Pre-glomerular structural changes in the renal vasculature in hypertension. Blood Press 1995;4(suppl 2):74-80.
25. Kett MM, Anderson WP, Bertram JF, Alcorn D: Structural changes in the renal vasculature in the spontaneous hypertensive rat: No effect of angiotensin blockade. Clin Exp Pharmacol Physiol Suppl 1996;3:132-135.
26. Anderson S, Vora JP: Currents concepts of renal hemodynamics in diabetes. J Diabetes Complications 1995;9:304-307.
27. Inazu M, Sakai Y, Homma I: Contractile responses and calcium mobilization in renal arteries of diabetic rats. Eur J Pharmacol 1991;203:79-84.
28. Arikawa E, Verma S, Dumont A, McNeill J: Chronic bosentan treatment improves renal artery vascular function in diabetes. J Hypertens 2001;19:803-812.